RNS Number : 1183C
Volex PLC
15 October 2020

15 October 2020


Volex plc

("Volex" or the "Company")


Trading Update


Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is today issuing a trading update ahead of the scheduled announcement of the group's interim results for the 26 weeks ended 4 October 2020, on 12 November 2020. 



We are continuing to monitor the global situation in respect of COVID-19. The health, safety and well-being of our colleagues remain our principal responsibility and we are providing our facilities with our full support, following all public health advice, and complying with all government directives. All manufacturing facilities remained fully operational following adaptations that were made in the first quarter in response to the COVID-19 pandemic.




Volex's performance has continued to improve since the group last updated the market at our Annual General Meeting on 30 July 2020.


Consequently, the board now expects revenue and profitability to be above current market expectations for both the half-year period and the full year as a whole. 


·  Unaudited revenue for the six months ended 4 October 2020 is expected to be at least $200 million, which represents an increase of 2.2 per cent over the same period a year earlier;


·  Underlying operating profit is expected to be at least $20 million, which represents an increase of 25.8 per cent over the same period a year earlier;


·  Net cash excluding lease liabilities as at 2 October 2020 was approximately $31 million.


Executive Chairman Nat Rothschild commented:


"We enter the final quarter of calendar 2020 in a healthy position. Our geographic and customer diversification continues to provide the business with a high degree of visibility at this time while ongoing demand for consumer electronics remains strong and the global shift to electric vehicles gathers pace.


Absent another widespread COVID-19 related global lockdown, given the robust performance in the first half of the year, coupled with our strong forward order book position, the board expects to see a strong performance for the year as a whole that will be above current market expectations.


I would like to extend my sincere thanks to the entire Volex team for their invaluable contribution to this strong performance as we look ahead to the second half of the year with cautious optimism." 


For further information please contact:


Volex plc

+44 (0)7909 995 887

Nat Rothschild, Executive Chairman


Daren Morris, Chief Financial Officer



Powerscourt - Media Enquiries

+44 (0)20 7250 1446

James White


Jack Holden



N+1 Singer - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson


Iqra Amin



Panmure Gordon - Joint Broker

+44 (0)20 7886 2500

Hugh Rich


Nick Lovering





Volex plc (AIM:VLX) is a leading integrated manufacturing specialist. The Group designs and manufactures products that ensure a critical connection never fails and are used in everything from defibrillators and ventilators through to data networking equipment and vehicle telematics. Headquartered in the United Kingdom, Volex serves the needs of its blue-chip customer base from its manufacturing sites located across nine countries and three continents, employing over 6,000 people. Volex's products are sold through its own global sales force and through distributors to Original Equipment Manufacturers ('OEMs') and Electronic Manufacturing Services companies.  For more information please visit www.volex.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.